CSIMarket
 


Immunic Inc   (IMUX)
Other Ticker:  
 
 

IMUX's Free Cash Flow Growth by Quarter and Year

Immunic Inc 's Free Cash Flow results by quarter and year




IMUX Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -23.68 -13.96 -6.27
III Quarter September -13.60 -17.60 -11.91 -5.98
II Quarter June -15.76 -29.01 -9.23 -12.57
I Quarter March -20.68 -12.95 -11.03 -3.74
FY   -50.04 -83.24 -46.13 -28.56



IMUX Free Cash Flow third quarter 2022 Y/Y Growth Comment
Immunic Inc in the third quarter 2022 recorded free cash outflow of $ -13.60 millions.

According to the results reported in the third quarter 2022, Immunic Inc achieved the best Free Cash Flow growth in Major Pharmaceutical Preparations industry. While Immunic Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2022.




IMUX Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Immunic Inc 's third quarter 2022 Free Cash Flow $ -13.60 millions IMUX's Income Statement
Immunic Inc 's third quarter 2021 Free Cash Flow $ -17.60 millions Quarterly IMUX's Income Statement
New: More IMUX's historic Free Cash Flow Growth >>


IMUX Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Immunic Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Immunic Inc in the III. Quarter 2022 admitted free cash outflow of $ -13.60 millions, some analyst said, that current results are recovery relative to the -15.76 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential Free Cash Flow growth. While Immunic Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


IMUX's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Immunic Inc in the III. Quarter 2022 showed free cash outflow of $ -13.60 millions, it should be said, that those numbers point to improvement compare to the -15.76 millions in the second quarter.

Within Major Pharmaceutical Preparations industry Immunic Inc achieved highest sequential Free Cash Flow growth. While Immunic Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Immunic Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Sep 30 2021)
Cumulative Free Cash Flow 12 Months Ending $ -73.70 $ -77.65 $ -90.90 $ -83.17 $ -73.44
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Immunic Inc ' has realized cumulative trailing twelve months free cash outflow of $ -74 millions in the Sep 30 2022 period.

Immunic Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Immunic Inc ' has realized cumulative trailing twelve months free cash outflow of $ -74 millions in the Sep 30 2022 period.

Immunic Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Major Pharmaceutical Preparations Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
IMUX's Free Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for IMUX's Competitors
Free Cash Flow Growth for Immunic Inc 's Suppliers
Free Cash Flow Growth for IMUX's Customers

You may also want to know
IMUX's Annual Growth Rates IMUX's Profitability Ratios IMUX's Asset Turnover Ratio IMUX's Dividend Growth
IMUX's Roe IMUX's Valuation Ratios IMUX's Financial Strength Ratios IMUX's Dividend Payout Ratio
IMUX's Roa IMUX's Inventory Turnover Ratio IMUX's Growth Rates IMUX's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2022
Avantor Inc -1.37%$ -1.375 millions
Taitron Components Incorporated-1.85%$ -1.849 millions
Ensign Group Inc-3.71%$ -3.713 millions
Abbvie Inc -4.20%$ -4.197 millions
Stryker Corp-4.72%$ -4.716 millions
Select Medical Holdings Corp-4.74%$ -4.741 millions
Prestige Consumer Healthcare Inc -5.97%$ -5.971 millions
Utah Medical Products Inc-6.71%$ -6.710 millions
Mettler Toledo International Inc-6.79%$ -6.789 millions
Dynavax Technologies Corporation-7.02%$ -7.025 millions
Ironwood Pharmaceuticals inc -7.96%$ -7.957 millions
Luna Innovations Inc-7.98%$ -7.979 millions
Quest Diagnostics Inc-10.52%$ -10.517 millions
Reflect Scientific Inc -10.82%$ -10.823 millions
Horizon Therapeutics Public Limited Company-10.84%$ -10.845 millions
West Pharmaceutical Services Inc -11.15%$ -11.152 millions
Bionexus Gene Lab Corp -11.24%$ -11.239 millions
Gilead Sciences Inc -11.99%$ -11.989 millions
Progyny Inc -13.53%$ -13.529 millions
Organon and Co -13.86%$ -13.859 millions
Sotera Health Company-16.26%$ -16.258 millions
Nuvasive Inc-17.01%$ -17.008 millions
Atrion Corporation-17.09%$ -17.090 millions
Integra Lifesciences Holdings Corp-17.48%$ -17.475 millions
Biogen Inc -17.92%$ -17.919 millions
3m Company-18.30%$ -18.303 millions
Zoetis Inc -19.45%$ -19.449 millions
Teleflex Incorporated-23.10%$ -23.103 millions
Intuitive Surgical Inc -23.57%$ -23.574 millions
Align Technology inc -24.94%$ -24.935 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

APOG's Profile

Stock Price

APOG's Financials

Business Description

Fundamentals

Charts & Quotes

APOG's News

Suppliers

APOG's Competitors

Customers & Markets

Economic Indicators

APOG's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071